Investec Bank Plc has filed a Form 8.5 regulatory disclosure revealing share dealings in Advanced Medical Solutions Group Plc on 20th October 2026.
The disclosure was made under Rule 8.5 of the Takeover Code, which governs public dealing disclosures by exempt principal traders with recognised intermediary status.
Investec Bank Plc holds the role of Adviser and Joint Broker to Advanced Medical Solutions Group Plc, establishing its connection to the offer party named in the filing.
The disclosure covers ordinary share transactions only, with no cash-settled or stock-settled derivative transactions reported in the filing.
On the purchases side, Investec acquired 10,176 ordinary shares in Advanced Medical Solutions Group at a price of 282.25 pence per unit.
On the sales side, 5,244 ordinary shares were sold at a price of 282.5 pence per unit during the same dealing date.
The net position reflects a purchase of more shares than were sold, indicating a marginal increase in the firm’s holdings through its client-serving trading activity.
Investec confirmed that no indemnity arrangements, option agreements, or other formal or informal understandings existed that might constitute an inducement to deal or refrain from dealing.
The firm also confirmed no agreements relating to voting rights or future acquisition or disposal of securities referenced to any derivative instrument were in place.
The disclosure was filed on 21st October 2026, with contact for the filing attributed to Abhishek Gawde, reachable via the telephone number listed in the regulatory submission.
Advanced Medical Solutions Group Plc trades on the London Stock Exchange under the ticker AMS.L, and Investec Bank Plc trades under INVP.L, both subject to ongoing regulatory oversight during any applicable offer period.
